NCT05673902: Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis
- State
- Under way
- Phase
- Phase 3
- People
- 17 taking part
- Started
- 11 Dec 2020
- Primary completion
- Jan 2026
- Arms
- RPH-104 80 mg
- Results
- None posted
- 11 Dec 2020: Trial started
- 6 Jan 2023: Trial registered